21.3 C
New York
Wednesday, June 3, 2026

Tag: neuropathy

newssourceFORcompanyinformationcontent1marketreleases

AlphaCur Gains Momentum in 2025 as a Leading Formula for Neuropathy Nerve Health Support

AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025 
AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025

MedTech Manufacturer Juvent Joins the Inc. 5000 List of America’s Fastest-Growing Private Companies

Juvent joins the 2025 Inc. 5000, ranking #757 with 552% growth over 3 years, for its Micro-Impact Platform, which improves mobility, pain, and wellness.

Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial

- Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track as projected for Q4 2025 -

Arialief for Neuropathy Supplement: Official Launch of a New Hope for Sciatic Nerve Discomfort Relief

Discover the official launch of Arialief in United States, UK, NZ, Canada and Australia, a new supplement developed to support those suffering from neuropathy and sciatic nerve discomfort. Learn how this science-backed formulation aims to provide natural relief and improve nerve health. 
Discover the official launch of Arialief in United States, UK, NZ, Canada and Australia, a new supplement developed to support those suffering from neuropathy and sciatic nerve discomfort. Learn how this science-backed formulation aims to provide natural relief and improve nerve health.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNeuropathy

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers